Menghua Wu
-
- Urological Disorders and Treatments 4
- Urinary Bladder and Prostate Research 3
-
- Pediatric Urology and Nephrology Studies 3
-
- Bladder and Urothelial Cancer Treatments 7
- Urinary and Genital Oncology Studies 3
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Genetic factors in colorectal cancer 3
- Co-authors
- Bin ChenAtul J. ButteMarina SirotaYujia BaoRegina BarzilayShiyu ChangShihui YuHui Su
- Cited by
- UrologyGeneticsCancer Research
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Menghua Wu
28 papers receiving 192 citations
Peers
Comparison fields: 5 of 68
- Urology 14
- Genetics 45
- Cancer Research 23
- Pediatrics, Perinatology and Child Health 29
- Reproductive Medicine 12
Countries citing papers authored by Menghua Wu
This map shows the geographic impact of Menghua Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menghua Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menghua Wu more than expected).
Fields of papers citing papers by Menghua Wu
This network shows the impact of papers produced by Menghua Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menghua Wu. The network helps show where Menghua Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Menghua Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 6 | |
| 17 | Few-shot Text Classification with Distributional Signatures | 2020 | 23 |
| 18 | 2016 | 2 | |
| 19 | 2015 | 33 | |
| 20 | A multidisciplinary approach for the assessment of drug interactions with disease-modifying antirheumatic drugs | 2005 | 1 |
About Menghua Wu
Menghua Wu is a scholar working on Urology, Pathology and Forensic Medicine and Surgery, having authored 35 papers that have together received 195 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Urological Disorders and Treatments (4 papers), COVID-19 Clinical Research Studies (3 papers), Urinary Bladder and Prostate Research (3 papers), Genetic factors in colorectal cancer (3 papers), Pediatric Urology and Nephrology Studies (3 papers), Urinary and Genital Oncology Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Urology (14 citations), Genetics (45 citations) and Cancer Research (23 citations). Menghua Wu has collaborated with scholars based in China, United States and India. Frequent co-authors include Bin Chen, Atul J. Butte, Marina Sirota, Yujia Bao, Regina Barzilay, Shiyu Chang, Shihui Yu, Hui Su, Shuai Jiang and Weiwei Zhao. Their work appears in journals such as Nature Medicine, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.